Document is current
Any future updates will be listed below
-
Authors
Schoenen, Jean https://orcid.org/0000-0002-6506-6460
Van Dycke, Annelies
Versijpt, Jan
Paemeleire, Koen
- License Information
-
More Information
Article History
Received: 3 July 2023
Accepted: 21 July 2023
First Online: 1 August 2023
Declarations
:
: Not applicable.
: JS has received personal compensation from Allergan/Abbvie, Amgen/Novartis, Eli Lilly, Lundbeck, Teva, Man & Science and Balancair for consulting, serving on a scientific advisory board, and/or speaking and is an investigator for Eli Lilly, Novartis,and Teva. AvD has no competing interests.JV received personal fees and non-financial support from Teva, personal fees from Novartis and Lundbeck, andgrants and non-financial support from Allergan/Abbvie.KP has received personal compensation from Allergan/Abbvie, Amgen/Novartis, Eli Lilly, Lundbeck and Teva for consulting, serving on a scientific advisory board, and/or speaking and is a clinical trial investigator for Amgen/Novartis and Eli Lilly.
